Written By ESR News Blog Editor Thomas Ahearn On October 26, 2017, U.S. President Donald Trump officially declared “the opioid crisis a national public health emergency under federal law” and directed executive agencies “to fight the opioid crisis” during a speech at the White House. The growing awareness of an opioid crisis in America by employers …Continue reading "Opioid Crisis in America Will Lead to More Advanced Drug Testing for Opiates by Employers in 2018"
Written By ESR News Blog Editor Thomas Ahearn The U.S. Department of Transportation (DOT) has issued a final rule in the Federal Register that adds four semi-synthetic opioids – hydrocodone, oxycodone, hydromorphone, and oxymorphone – to its drug testing panel for DOT regulated industries, adds methylenedioxyamphetamine (MDA) as an initial test analyte, and removes the testing …Continue reading "DOT Issues Final Rule to Add Semi-Synthetic Opioids to Drug Testing Panel to Combat Opioid Epidemic"
Written By ESR News Blog Editor Thomas Ahearn On October 26, 2017, President Donald Trump officially declared “the opioid crisis a national public health emergency under federal law” and directed “all executive agencies to use every appropriate emergency authority to fight the opioid crisis” during remarks in the East Room of the White House.Continue reading "Drug Testing for Opioids Expected to Increase after President Trump Declares Opioid Crisis a National Public Health Emergency"
Written By ESR News Blog Editor Thomas Ahearn Even with the dramatic rise in the use of opioids – which can include the illegal drug heroin and legally prescribed pain relievers such as OxyContin® and Vicodin® – some employers hoping to avoid hiring opioid-addicted workers through drug testing may not know the best type of drug …Continue reading "Employers Need to Use Proper Drug Testing Panels to Fight Opioid Epidemic in Workplace"